Astec LifeSciences Limited Cash Flow Conversion Efficiency
Astec LifeSciences Limited cash flow conversion efficiency. Based on the latest financial reports, Astec LifeSciences Limited (ASTEC) has a cash flow conversion efficiency ratio of -0.036x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-83.99 Million ≈ $-908.28K USD) by net assets (Rs2.35 Billion ≈ $25.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Astec LifeSciences Limited (2008–2025)
Cash flow conversion efficiency of Astec LifeSciences Limited from 2008 to 2025. This chart illustrates how Astec LifeSciences Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ASTEC share price today for real-time trading data and today's change.
Astec LifeSciences Limited Cash Flow Conversion Ratio Explained
Astec LifeSciences Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Astec LifeSciences Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Astec LifeSciences Limited ranked by their cash flow conversion efficiency. Also see how much is Astec LifeSciences Limited worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Baiksan
KO:035150
|
0.040x |
|
Ekovest Bhd
KLSE:8877
|
0.159x |
|
Dynacons Systems & Solutions Limited
NSE:DSSL
|
0.031x |
|
Blue Water Acquisition Corp. IV
NYSE:BWIV
|
0.350x |
|
Thailand Prime Property Freehold and Leasehold Real Estate Investment Trust
BK:TPRIME
|
0.014x |
|
Bright Sheland International Co Ltd
TWO:4556
|
0.038x |
|
Orion Minerals Ltd
AU:ORN
|
-0.059x |
|
Eastern Co
NASDAQ:EML
|
0.031x |
Annual Cash Flow Conversion Efficiency for Astec LifeSciences Limited (2008–2025)
The table below shows the annual cash flow conversion efficiency of Astec LifeSciences Limited from 2008 to 2025. Review ASTEC free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs2.35 Billion ≈ $25.42 Million |
Rs-83.99 Million ≈ $-908.28K |
-0.036x | -229.20% |
| 2024-03-31 | Rs3.70 Billion ≈ $39.96 Million |
Rs102.21 Million ≈ $1.11 Million |
0.028x | -84.46% |
| 2023-03-31 | Rs4.20 Billion ≈ $45.37 Million |
Rs746.56 Million ≈ $8.07 Million |
0.178x | +199.02% |
| 2022-03-31 | Rs3.97 Billion ≈ $42.90 Million |
Rs236.04 Million ≈ $2.55 Million |
0.060x | +325.51% |
| 2021-03-31 | Rs3.09 Billion ≈ $33.45 Million |
Rs-81.62 Million ≈ $-882.72K |
-0.026x | -103.87% |
| 2020-03-31 | Rs2.47 Billion ≈ $26.70 Million |
Rs1.68 Billion ≈ $18.22 Million |
0.682x | +805.15% |
| 2019-03-31 | Rs2.03 Billion ≈ $21.93 Million |
Rs152.85 Million ≈ $1.65 Million |
0.075x | -80.20% |
| 2018-03-31 | Rs1.70 Billion ≈ $18.38 Million |
Rs646.75 Million ≈ $6.99 Million |
0.381x | +173.44% |
| 2017-03-31 | Rs1.38 Billion ≈ $14.94 Million |
Rs192.32 Million ≈ $2.08 Million |
0.139x | +401.11% |
| 2016-03-31 | Rs1.17 Billion ≈ $12.65 Million |
Rs-54.05 Million ≈ $-584.56K |
-0.046x | -137.74% |
| 2015-03-31 | Rs1.35 Billion ≈ $14.64 Million |
Rs165.82 Million ≈ $1.79 Million |
0.122x | -21.96% |
| 2014-03-31 | Rs1.14 Billion ≈ $12.28 Million |
Rs178.19 Million ≈ $1.93 Million |
0.157x | +1.12% |
| 2013-03-31 | Rs1.06 Billion ≈ $11.45 Million |
Rs164.31 Million ≈ $1.78 Million |
0.155x | +77.15% |
| 2012-03-31 | Rs987.06 Million ≈ $10.67 Million |
Rs86.48 Million ≈ $935.23K |
0.088x | -48.14% |
| 2011-03-31 | Rs970.25 Million ≈ $10.49 Million |
Rs163.91 Million ≈ $1.77 Million |
0.169x | +50.01% |
| 2010-03-31 | Rs931.08 Million ≈ $10.07 Million |
Rs104.85 Million ≈ $1.13 Million |
0.113x | +252.98% |
| 2009-03-31 | Rs325.25 Million ≈ $3.52 Million |
Rs-23.94 Million ≈ $-258.93K |
-0.074x | -109.22% |
| 2008-03-31 | Rs229.75 Million ≈ $2.48 Million |
Rs183.53 Million ≈ $1.98 Million |
0.799x | -- |
About Astec LifeSciences Limited
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maiz… Read more